Saratoga Therapeutics, LLC Issues Allergy Alert On Undeclared Milk Components In ebA Multivitamin Supplement

Apr 26, 2013, 09:19 ET from Saratoga Therapeutics, LLC

NORTH WALES, Pa., April 26, 2013 /PRNewswire/ -- Saratoga Therapeutics, LLC of North Wales, PA is recalling 900 bottles of ebA Multivitamin Supplement because they may contain undeclared milk components –milk protein(s) and lactose. The following lot numbers may be affected:

  • # 0912164    expiration date 12/12
  • # 1110354    expiration date 10/14

(Photo: )

People with an allergy or severe sensitivity to milk run the risk of a serious or life-threatening allergic reaction and people who have lactose intolerance run the risk of gastrointestinal symptoms if they consume ebA Multivitamin Supplement.

ebA Multivitamin Supplement was distributed nationwide and in Australia, Canada, Costa Rica, England, Finland, Ireland, Malaysia, and Switzerland, and reached consumers by mail order, fax order, internet sales and doctors' office sales.  The vitamins are packaged in a white plastic bottle with white, green and blue labeling.  The expiration date is listed beneath the Warning section on the label. The label erroneously lists the product as being free of milk components.

One customer with a known milk allergy reported an anaphylactic reaction to ebA and recovered completely with appropriate treatment.  Another customer with a reported milk allergy reported being "sick" while taking ebA.

The milk components were discovered by the distributor, Saratoga Therapeutics, LLC, via outside laboratory analysis, after being informed of the anaphylactic reaction.  The source of the milk components is under investigation by the third party, U.S.-based manufacturer of the vitamin tablets.

Consumers who have purchased ebA Multivitamin Supplement may return any unused portion of the product to Saratoga Therapeutics, LLC for a full refund.  Contact the company at or 215-661-9044 8:30 a.m. to 4:30 p.m. east coast time to request mailing materials and/or for any questions.

SOURCE Saratoga Therapeutics, LLC